Author

Frank Peprah

Dana-Farber Cancer InstituteORCID 0009-0004-6213-487XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Organism:mouse· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

Chan Johng KimiD· 2 shared David A. BakeriD· 2 shared Hojeong ShiniD· 2 shared Julissa G. TelloiD· 2 shared Jung-Ho ChuniD· 2 shared Michael Lawrence DouganiD· 2 shared Stephanie K. DouganiD· 2 shared Tavus AtajanovaiD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Chan Johng KimORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintSep 22, 2026

De novo design of protease-activatable cytokine prodrugs

Hojeong Shin, Julissa G. Tello, Chan Johng Kim…·David A. Baker

This study designs protease-activatable cytokine prodrugs to reduce toxicity while maintaining antitumor efficacy in tumor models.

DOI 10.64898/2026.09.19.752834

protein structureexperimental assay

𝕏 PostBluesky

BiochemistryScience ImmunologyPeer-reviewedSep 26, 2025

Potent antitumor activity of a designed interleukin-21 mimic

Jung-Ho Chun, Birkley S. Lim, Suyasha Roy…·David A. Baker

This paper describes a designed IL-21 mimic, 21h10, which shows potent antitumor activity in multiple models and reduces toxicity through TNF blockade.

20 citationstop 2%

𝕏 PostBluesky